| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > PPC Publishing > Fewer Ads, Fewer Clicks? |
|
Digg It - Fewer Ads, Fewer Clicks?
You’ve probably noticed by now that Google has started to automatically change the number of ads in your ad According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product units. If they see that most people are clicking on just one ad, they’re going to take out the others and ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in eave you with just that one highest-earning link. Now that sounds like a great idea and I’m all in favor o lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. f focusing on whatever earns the most. It’s the second part of the process that bothers me: once they’ve ta here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe en out the other ads, Google expands the one remaining ad to fill the space that’s left. Why does that bot d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro her me? Because it breaks one of the golden rules of successful AdSense advertising: that your ads have to ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc blend into the page. Google provides a whole range of tools that you can use to make your ads match the res easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi t of the page. If you’ve been using them — and you should be using them — then all your hard work is going nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically o be ruined. The same goes for any images or anything else that you’ve been putting next to your ad units t and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ o draw the reader’s eye without them noticing that they’re being pulled towards an ad. In Google’s new sys ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi em, your ads are going to be blown up like balloons. That might work for blimps, but online we don’t get pa ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a d when people look at ads; we get paid when they click on ads and I think that fewer people are going to be dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod clicking when your ad units scream “I’m an advertiser!” I could be wrong — that’s happened — and Google s cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin y they’re only going to use this system when they see that it increases CTR. But in the meantime, I think i tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen t’s a good idea to keep a close eye on your site as well as your stats to make sure that all your pages loo t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel the way you want them to look, not the way Google makes them look. From The Horse’s Mouth You can read a ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ll about this new change on Google’s blog at adsense.blogspot.com. If you haven’t checked it out already, I y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products recommend it. It’s a great resource. You won’t just get the news but unlike user blogs (which are certainly . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de worth reading too) you can be confident know that any changes you read here are the genuine article. No ru elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ors and no stories. The facts straight from the horse’s mouth. Make it a part of your AdSense news browsing tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:CRM ...The Emperor's New Clothes Business Blogging Benefits - Making the Case for Business Blogs
|